Asian stocks mixed after weak China trade data; US jobs watched: CNBC

YEREVAN, January 10. /ARKA/. Asian equity markets ended mixed on Friday following a weak trade report from China and as caution prevailed ahead of the much-anticipated December U.S. jobs report.

China’s December trade surplus came in at $25.6 billion, far short of the $31.15 billion Reuters predicted, while exports rose an annual 4.3 percent last month, missing estimates for a 4.9 percent rise. Imports however, beat expectations to jump an annual 8.3 percent.

“Perhaps the fact that the numbers out of China aren’t that bad suggests there is no need for officials to loosen policy, which is deemed a negative by some investors,” said Stan Shamu, market strategist at IG in a note.

Meanwhile, investors were awaiting Friday’s non-farm payrolls report, due out later in the global day. Market expectations are for a payrolls number around 197,000 jobs, with the unemployment rate seen at 7 percent. –0—

spot_img

POPULAR

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img